Searchable abstracts of presentations at key conferences in endocrinology

ea0093oc40 | Oral communication 6: Thyroid Diseases and Tumors | EYES2023

Thyroid hormone (TH) action in acute and chronic ischemic heart disease

Dorr Stefanie , Grund Susanne , Hones G. Sebastian , Fuhrer Dagmar , Moller Lars Christian , Lorenz Kristina

Ischemic heart disease (IHD) is one of the leading causes of death worldwide. TH have impact on cardiac function and even appear to improve outcome after acute ischemia/reperfusion and in chronic heart failure. This project aims to investigate the influence of TH receptor alpha (TRα) on IHD using specific mouse models to assess the contribution of canonical vs. non-canonical TH signaling. Mice underwent permanent ligation of the left descending coronary artery and were tr...

ea0099p22 | Adrenal and Cardiovascular Endocrinology | ECE2024

Update on autoimmune polyendocrine syndrome type-1 in Norway: Using longitudinal immune cell composition incorporated with clinical features

Kucuka Isil , Iraji Dorsa , Breivik Lars , Husebye Eystein Sverre , Wolff Anette Boe , Oftedal Bergithe

Autoimmune Polyendocrine Syndrome type-1 (APS-1) is a rare monogenic disease (1:100 000 frequency), caused by mutations in the autoimmune regulator (AIRE) gene, which plays a crucial role in the thymus for negative selection of self-reacting T cells. With tissue damage caused by self-reactive immune cells from early stages of life and gradually presenting with symptoms in following years, APS-1 is clinically diagnosed by presence of minimum two components of the classical tria...

ea0099p91 | Endocrine-Related Cancer | ECE2024

Clinical impact and genetic alterations in the DAXX gene in patients with neuroendocrine tumors of the gastroenteropancreatic system and the lung

Katalinic Darko , Toetome Lars , Aleric Ivan , Skrlec Ivana , Talapko Jasminka , Vcev Aleksandar

Introduction: Neuroendocrine tumors (NETs) comprise a unique heterogeneous group of malignant growths that range from benign and multi-focal to highly malignant and metastatic. They are characterized by well-differentiated morphologic features and the ability to secrete neuropeptides, resulting in characteristic clinical syndromes. However, they are often diagnosed from the metastases of an unknown primary tumor. Therefore, high-quality genetic and immunohistochemical markers ...

ea0084op-06-31 | Oral Session 6: Hypothyroidism | ETA2022

Does subclinical hypothyroidism add on any symptoms? evidence from a danish population-based study

Carle Allan , Karmisholt Jesper , Knudsen Nils , Perrild Hans , Thuesen Betina , Ovesen Lars , B Rasmussen Lone , Bulow Pedersen Inge

Background: Few studies have scrutinized the spectrum of symptoms in subclinical hypothyroidism.Methods: From three DanThyr cross-sectional surveys performed in the period 1997 to 2005, a total of 8,903 volunteers participated in a comprehensive investigation including blood samples and questionnaires on previous diseases, smoking habits, alcohol intake, and education. From the three surveys we included patients with unknown subclinical hypothyroidism (<...

ea0063oc1.4 | Calcium and Bone | ECE2019

Risk of sepsis, respiratory infections, and kidney or other genitourinary (GU) infections in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study

Chen Kristina , Curhan Gary , Gosmanova Elvira , Mu Fan , Briggs Allison , Pajerowski William , Sherry Nicole , Ketteler Markus , Rejnmark Lars

Background: Prior small studies have suggested increased risk of infections in patients with hypoparathyroidism (HypoPT). This study using a large managed care cohort evaluated whether chronic HypoPT is associated with increased risk of sepsis, respiratory infections, and kidney or other genitourinary (GU) infections.Methods: A retrospective cohort study using a US commercial claims database (Q1 2007–Q2 2017) was conducted to examine the association...

ea0063gp80 | Thyroid Autoimmune Disorders | ECE2019

Effect of nine months of vitamin D supplementation on muscle performance in Graves’ disease: a double-blinded, randomized clinical trial

Grove-Laugesen Diana , Malmstrom Sofie , Ebbehoj Eva , Riis Anne Lene , Watt Torquil , Hansen Klavs Wurgler , Rejnmark Lars

Background: Vitamin D deficiency has been proposed to play a role in development and course of Graves’ disease (GD). Muscle weakness and fatigue are shared features of GD and vitamin D deficiency. We aimed to investigate whether vitamin D supplementation would improve restoration of muscle performance and thyroid-related quality of life (QoL) in GD.Methods: In a double-blinded clinical trial, hyperthyroid patients with a first time diagnosis of GD w...

ea0063gp147 | Interdisciplinary Endocrinology 1 | ECE2019

Risk of nephrolithiasis and nephrocalcinosis in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study

Chen Kristina , Curhan Gary , Gosmanova Elvira O. , Rejnmark Lars , Swallow Elyse , Macheca Monica , Briggs Allison , Sherry Nicole , Ketteler Markus

Background: Little is known about the risk of developing nephrolithiasis and nephrocalcinosis in patients with chronic HypoPT treated with conventional therapy (ie, oral calcium and active vitamin D). This study evaluated whether HypoPT is associated with increased risk of these conditions.Methods: This retrospective cohort study, based on a large US commercial claims database (Q1 2007–Q2 2017), was conducted to compare the risk of nephrolithiasis a...

ea0063gp149 | Interdisciplinary Endocrinology 1 | ECE2019

Risk of chronic kidney disease (CKD) and CKD progression in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study

Chen Kristina , Gosmanova Elvira O. , Curhan Gary , Rejnmark Lars , Mu Fan , Swallow Elyse , Sherry Nicole , Macheca Monica , Ketteler Markus

Background: Previous studies of smaller size signaled heightened risk of CKD in patients with chronic HypoPT treated with conventional therapy (ie, oral calcium and active vitamin D). However, little is known about CKD progression, including progression to end-stage kidney disease (ESKD), in HypoPT patients.Methods: A retrospective cohort study, using a large US commercial claims database (Q1 2007–Q2 2017), was conducted to compare the risk of CKD b...

ea0063gp157 | Cushing's | ECE2019

DNA Methylation and fMRI responses in patients with Cushing’s syndrome in remission – suggestions of a functional link between hypercortisolism and neurocognitive dysfunction

Glad Camilla , Andersson-Assarsson Johanna , Stomby Andreas , Dahlqvist Per , Nyberg Lars , Bergthorsdottir Ragnhildur , Johannsson Gudmundur , Ragnarsson Oskar

Introduction: Compared with healthy controls, women with Cushing’s syndrome (CS) in long-term remission have reduced functional brain responses during episodic and working memory testing and decreased overall levels of DNA methylation in blood cells. Here, we sought to test the hypothesis that functional brain responses in the prefrontal cortex and hippocampus are related to epigenetic changes in subjects with CS in long-term remission.Methods: In t...

ea0063p795 | Thyroid 2 | ECE2019

Effect of vitamin D supplementation on cardiovascular indices in Graves’ disease. A randomized clinical trial

Grove-Laugesen Diana , Malmstroem Sofie , Ebbehoj Eva , Riis Anne Lene , Watt Torquil , Hansen Klavs Wurgler , Rejnmark Lars

Background: Risk of cardiovascular disease (CVD) and mortality is increased in Graves’ disease (GD) even years after initial diagnosis and treatment. The mechanisms are incompletely understood. Vitamin D insufficiency is associated with an increased risk of CVD and has been reported to occur frequently in GD. Pulse wave velocity (PWV) and blood pressure (BP) are important predictors of CVD. We performed a clinical trial, testing whether vitamin D supplementation affects P...